| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H18FN5O3 |
| Molecular Weight | 371.3656 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@H](N1C(=O)NC2=C(C(C)=CN=C2)C1=O)C(=O)NC3=CC(F)=NC=C3
InChI
InChIKey=VHGMWHLRBQVHCO-HNNXBMFYSA-N
InChI=1S/C18H18FN5O3/c1-9(2)15(16(25)22-11-4-5-21-13(19)6-11)24-17(26)14-10(3)7-20-8-12(14)23-18(24)27/h4-9,15H,1-3H3,(H,23,27)(H,21,22,25)/t15-/m0/s1
| Molecular Formula | C18H18FN5O3 |
| Molecular Weight | 371.3656 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
|
|
TARGET ORGANISM->INHIBITOR |
Could not achieve a single dose cure regimen.
IC50
30 NANOMOLAR (average) |
||
|
|
TARGET ORGANISM->INHIBITOR |
IC50
140 NANOMOLAR (average) |
Showing 1 to 2 of 2 entries
